Oxidized regenerated cellulose gauze as a hemostat in infantile hypertrophic pyloric stenosis
Keywords:Hemostat, Infantile hypertrophic pyloric stenosis, Outcome, Oxidized regenerated cellulose gauze, Pyloromyotomy, Ramstedt
Background: The Ramstedt pyloromyotomy is a standard procedure for infantile hypertrophic pyloric stenosis (IHPS). However, continuous postoperative bleeding may occur from the pyloromyotomy site without the use of any hemostatic management. We aim to analyze the pre-operative and post-operative hemogram values with and without the use of oxidized regenerated cellulose gauze as a hemostat in IHPS.
Methods: A prospective study performed from January 2019 to March 2020. The patients were randomly distributed by chit method into two groups: Group A (Control) without the use of hemostat and Group B (Case) with oxidized regenerated cellulose gauze as a hemostat.
Results: There were 26 patients with 19 males and 7 females. There were 13 patients in Group A and 12 in Group B; while one patient succumbed before surgery. Ramstedt’s pyloromyotomy was performed in 25 (96.16%) patients. A total of 7 (28%) postoperative complications were recorded in our patients. One patient in group A with intraperitoneal blood collection required blood transfusion for anemia caused by peritoneal bleeding. There was one postoperative death (group A). Significant statistical differences between preoperative and postoperative RBC (106/mm3), hemoglobin (g/dl), and hematocrit (%) levels were observed in group A but insignificant differences among the values in group B.
Conclusions: We recommend that oxidized regenerated cellulose should be applied to the pyloromyotomy site to minimize perioperative bleeding associated with the Ramstedt procedure. It appears to be a safe, easily available, easy to use, and effective hemostatic agent available for IHPS.
Handu AT, Jadhav V, Deepak J, Aihole JS, Gowrishankar, Narendrababu M, et al. Laparoscopic pyloromyotomy: Lessons learnt in our first 101 cases. J Indian Assoc Pediatr Surg. 2014; 19:213-7.
Raveenthiran V. Centennial of pyloromyotomy. J Neonatal Surg. 2013; 2:8.
Yamazaki Y, Yoshida T, Mizuno R, Yuno S, Hara A, Yoshizawa J, et al. Hemostasis for the Ramstedt procedure: use of a fibrin adhesive. Pediatr Surg Int. 1994; 9:455-6.
Ladd WE, Ware PF, Pickett LK. Congenital hypertrophic pyloric stenosis. JAMA. 1946; 131:647-51.
Walker K, Halliday R, Holland AJA, Karskens C, Badawi N. Early developmental outcome of infants with infantile hypertrophic pyloric stenosis. J Pediatr Surg. 2010; 45:2369-72.
Hernanz-Schulman M. Infantile hypertrophic pyloric stenosis. Radiol. 2003; 227:319-31. Available from: https://doi.org/10.1148/radiol.2272011329.
Perger L, Fuchs JR, Komidar L, Mooney DP. Impact of surgical approach on outcome in 622 consecutive pyloromyotomies at a pediatric teaching institution. J Pediatr Surg. 2009; 44:2119.
Chalya PL, Manyama M, Kayange NM, Mabula JB, Alicia Massengaet A. Infantile hypertrophic pyloric stenosis at a tertiary care hospital in Tanzania: a surgical experience with 102 patients over a 5-year period. BMC Res Notes. 2015; 8:690. Available from: https://doi.org/10.1186/s13104-015-1660-4.
To T, Wajja A, Wales PW, Langer JC. Population demographic indicators associated with the incidence of pyloric stenosis. Arch Pediatr Adolesc Med. 2005; 159:520.
Taylor ND, Cass DT, Holland AJA. Infantile hypertrophic pyloric stenosis: Has anything changed? J Paediatr Child Health. 2013; 49:33-7. Available from: https://doi.org/10.1111/jpc.12027.
Abraham C. Post-operative outcomes of oxidized regenerated cellulose use in women undergoing cesarean delivery. Gynecol Obstet Res Open J. 2017; 4:1-4. Available from: https://doi.org/10.17140/GOROJ-4-136.
Genyk Y, Kato T, Pomposelli JJ, Wright JJK, Sher LS, Tetens V, et al. Fibrin sealant patch (TachoSil) vs oxidized regenerated cellulose patch (Surgicel Original) for the secondary treatment of local bleeding in patients undergoing hepatic resection: A randomized controlled trial. J Am Coll Surg. 2016; 222:216-8.
Menovsky T, Plazier M, Rasschaert R, Maas AIR, Parizel PM, Verbeke S. Massive swelling of surgicel ® fibrillar™ hemostat after spinal surgery. Case report and a review of the literature. Minim Invas Neurosurg. 2011; 54:257-9. Available from: https://doi.org/10.1055/s-0031-1284394.
Kim SH, Kim SH, Yoon HS, Kim HK, Kim KS. Efficacy of oxidized regenerated cellulose, SurgiGuard®, in porcine surgery. Yonsei Med J. 2017; 58:195-205.
Lewis KM, Spazierer D, Urban MD, Lin L, Redl H, Goppelt A. Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents. Eur Surg. 2013; 45:213-20.
Patanè F, Zingarelli E, Verzini A, Summa M. Complication due to excessive use of Surgicel. Eur J Cardiothorac Surg. 2001; 20:1075-6.
Arora ND, Varghese R, Pavithran S, Kothandam S. The pressures of surgicel® in cardiac surgery. Ann Pediatr Cardiol. 2015; 8:167-9. Available from: https://doi.org/10.4103/0974-2069.157040.
Brodbelt AR, Miles JB, Foy PM, Broome JC. Intraspinal oxidised cellulose (Surgicel) causing delayed paraplegia after thoracotomy - a report of three cases. Ann R Coll Surg Engl. 2002; 84:97-9.
How to Cite
Copyright (c) 2020 Rahul Gupta, Anu Bhandari
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.